Mark Surka

Mark Surka is currently the Head of Medical Affairs for Oncology, Rare, and Rare Blood Diseases at Sanofi, with an extensive background in medical affairs and scientific leadership. They have held significant roles at companies such as Janssen, Bristol-Myers Squibb, and Sanofi Genzyme, showcasing expertise in oncology and hematology. Mark earned a Ph.D. in Biochemistry from the University of Toronto and a BSc in Biochemistry and Chemistry from Western University. Their previous positions also include a Medical Science Liaison role at Bristol-Myers Squibb and a Scientific Lead in Oncology/Nephrology at Janssen.